Loading...
THC Therapeutics, Inc.
THCT•PNK
Healthcare
Drug Manufacturers - Specialty & Generic
$0.02
$0.02(9400.00%)
U.S. Market is Open • 13:47THC Therapeutics, Inc. (THCT) AI-Powered Stock Analysis
See how THC Therapeutics, Inc. scores across key metrics like financial growth, valuation, and market position using AI-driven evaluation.
Model Information
The AI Stock Analysis Model is provided for informational purposes only and should not be considered financial advice. We are continously improving this model to increase accuracy and performance.Read our Full DisclaimerTHC Therapeutics, Inc. (THCT) Stock Overall Grade
THC Therapeutics, Inc.’s grade based on a comprehensive AI analysis of financial metrics, growth potential, and market position.
Z
Grade Breakdown by Metric
See how each financial and market factor contributes to THC Therapeutics, Inc.'s overall stock rating.
Forecast
C+Score
54/100Financial Growth
CScore
40/100Fundamental Growth
BScore
61/100Key Ratios
BScore
63/100Sector Comparison
B+Score
75/100Industry Comparison
C+Score
50/100S&P 500 Benchmark
A+Score
94/100Analyst Consensus
C+Score
50/100THC Therapeutics, Inc. (THCT) AI-Powered Stock Analysis
This asset demonstrates Good performance with an overall Forecast Score of 54/100 (C+), reflecting weak confidence in its potential. Financial Growth (40/100, C) and Fundamental Growth (61/100, B) highlight its stability, while Key Ratios (63/100, B) and Sector Comparison (75/100, B+) indicate solid positioning. Compared to broader benchmarks like the S&P 500 (94/100, A+), it shows competitive strength. Analyst Consensus (50/100,C+) suggests High divergence in outlook.Component Analysis Explained
Understand the key factors behind each THC Therapeutics, Inc. stock grade, including financials, comparisons, and forecasts.